The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrave Bison Regulatory News (BBSN)

Share Price Information for Brave Bison (BBSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.60
Bid: 2.55
Ask: 2.65
Change: 0.075 (2.97%)
Spread: 0.10 (3.922%)
Open: 2.525
High: 2.65
Low: 2.525
Prev. Close: 2.525
BBSN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)

2 Jun 2017 11:30

RNS Number : 0105H
Stockdale Securities Limited
02 June 2017
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Stockdale Securities Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Brave Bison Group Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

As above

(d) Date dealing undertaken:

01 06 2017

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary

Sale

36,944

1.34p

1.34p

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

Date of disclosure:

02 June 2017

Contact name:

Andrew Proctor

Telephone number:

0207 601 6106

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERZMGGVGZRGNZM
Date   Source Headline
6th Jun 20184:35 pmRNSPrice Monitoring Extension
22nd May 201811:30 amRNSWorld's 3rd biggest digital media publisher
14th May 20184:04 pmRNSPosting of Annual Report and Notice of AGM
14th May 20188:02 amRNSBrave Bison launches partnership with UNRULY
25th Apr 20187:00 amRNSBoard Change
6th Apr 201812:15 pmRNSLaunches PUMA branded content campaign
22nd Mar 201810:28 amRNSBranded Content Series for Courtyard by Marriott
21st Mar 20187:00 amRNSFinal Results
14th Mar 20187:00 amRNSChange of Adviser and Notice of Results
9th Mar 201811:19 amRNSDirector Declaration
1st Mar 201812:00 pmRNSRenews partnership with All Nippon Airways
20th Feb 20187:00 amRNSNew APAC General Manager - Caroline Troman
14th Feb 20187:00 amRNSRebel FC sign deal with Under Armour
19th Jan 20187:30 amRNSDirector/PDMR Shareholding
17th Jan 201810:43 amRNSExercise of options
14th Dec 20177:00 amRNSBrave Bison and Shell renew strategic partnership
7th Dec 20177:00 amRNSTrading Update
27th Nov 20171:00 pmRNSShare Incentive Scheme and Grants to Directors
25th Oct 201711:00 amRNSHolding(s) in Company
23rd Oct 20177:00 amRNSEFL renews digital business with Brave Bison
11th Oct 20177:00 amRNSVideo marketing campaign for All Nippon Airways
20th Sep 20172:31 pmRNSIssue of Equity
20th Sep 20177:00 amRNSDirectorate Change
18th Sep 20177:00 amRNSDirectorate Change
12th Sep 20177:00 amRNSAppointment of non-Board Commercial Director
14th Aug 20177:00 amRNSAppointment of Chief Financial Officer
31st Jul 20177:00 amRNSHalf-year Report
10th Jul 20177:00 amRNSSenior Management Update
21st Jun 201711:37 amRNSResult of AGM
21st Jun 201711:00 amRNSCEO Appointment and AGM Statement
15th Jun 20177:00 amPRNForm 8.3 - Brave Bison Group
13th Jun 20175:31 pmRNSForm 8.5 (EPT/RI)
13th Jun 20172:34 pmRNSForm 8.3 - Brave Bison Group plc
12th Jun 20173:30 pmRNSRule 2.8 Announcement
12th Jun 201711:46 amRNSForm 8.5 (EPT/RI)
8th Jun 201711:29 amRNSForm 8.5 (EPT/RI)
6th Jun 201711:20 amRNSForm 8.5 (EPT/RI)
5th Jun 20173:00 pmRNSForm 8.3 - Brave Bison Group Plc
5th Jun 201711:57 amRNSForm 8.5 (EPT/RI)
2nd Jun 20172:45 pmRNSForm 8 (OPD) Zinc Media Group plc - Replacement
2nd Jun 20171:22 pmRNSForm 8.3 - Brave Bison Grp PLC
2nd Jun 20171:09 pmRNSForm 8.3 - Brave Bison Grp - Submission Amendment
2nd Jun 201711:30 amRNSForm 8.5 (EPT/RI)
2nd Jun 20177:00 amRNSForm 8.3 - Brave Bison Group plc
1st Jun 20175:41 pmRNSForm 8.3 - Zinc Media Group plc
1st Jun 20174:10 pmRNSForm 8.3 - Brave Bison plc
1st Jun 20179:54 amRNSForm 8.5 (EPT/RI)
31st May 20173:15 pmRNSForm 8 (OPD) - Zinc Media Group plc
31st May 20173:15 pmRNSForm 8 (OPD) - Brave Bison Group plc
31st May 201711:59 amRNSForm 8.3 - Zinc Media Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.